Shares of Sun Pharma came under massive selling Friday, tumbling over 13 per cent, amid reports of fresh allegations by a whistleblower against the company.
The scrip after a weak opening further tumbled 12.11 per cent to hit a multi-year low of Rs 375.40 on BSE.
At NSE, shares of the company plummeted 13.21 per cent to hit a low of Rs 370.20.
The stock was the worst hit among the blue chips on both the key indices during the morning trading session.
In terms of equity volume, 38.20 lakh shares of the company were traded on BSE and over 4 crore shares changed hands at NSE during the day.
According to reports, the complaint, sent to the capital market regulator SEBI, is the second in over a month.
Meanwhile, the BSE has sought clarification from Sun Pharmaceutical Industries on January 18, 2019, with reference to news that Sun Pharma plummets over buzz of fresh whistleblower complaint.
A whistleblower had in November last year approached Sebi with a document alleging various irregularities by the company, its promoter and others.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app